116 related articles for article (PubMed ID: 10079388)
21. [Significance of CEA and CA242 in the diagnosis of colorectal carcinoma].
Wu J; Yu H; Shao Y
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):438-40. PubMed ID: 8697997
[TBL] [Abstract][Full Text] [Related]
22. Serum values of CA72.4 in patients with gastrointestinal system tumors comparison with CEA and CA 19.9.
Yasasever V; Sengün Z; Saydan N; Onat H; Dalay N
Eur J Gynaecol Oncol; 1992; 13(5):403-8. PubMed ID: 1486919
[TBL] [Abstract][Full Text] [Related]
23. The clinical value of the tumor markers CA 19/9 and carcinoembryonic antigen (CEA) in colorectal carcinomas: a critical comparison.
von Kleist S
Int J Biol Markers; 1986; 1(1):3-8. PubMed ID: 3480321
[TBL] [Abstract][Full Text] [Related]
24. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
25. CA11-19: a tumor marker for the detection of colorectal cancer.
Overholt BF; Wheeler DJ; Jordan T; Fritsche HA
Gastrointest Endosc; 2016 Mar; 83(3):545-51. PubMed ID: 26318832
[TBL] [Abstract][Full Text] [Related]
26. Effect of Incorporation of Pretreatment Serum Carcinoembryonic Antigen Levels Into AJCC Staging for Colon Cancer on 5-Year Survival.
Thirunavukarasu P; Talati C; Munjal S; Attwood K; Edge SB; Francescutti V
JAMA Surg; 2015 Aug; 150(8):747-755. PubMed ID: 26083632
[TBL] [Abstract][Full Text] [Related]
27. Clinical value of a diagnostic score for colon cancer based on serum CEA, CA19-9, cytokeratin-1 and mucin-1.
Attallah AM; El-Far M; Ibrahim AR; El-Desouky MA; Omran MM; Elbendary MS; Attallah KA; Qura ER; Abdallah SO
Br J Biomed Sci; 2018 Jul; 75(3):122-127. PubMed ID: 29734875
[TBL] [Abstract][Full Text] [Related]
28. The value of the tumor marker CA 15-3 in diagnosing and monitoring breast cancer. A comparative study with carcinoembryonic antigen.
Safi F; Kohler I; Röttinger E; Beger H
Cancer; 1991 Aug; 68(3):574-82. PubMed ID: 2065278
[TBL] [Abstract][Full Text] [Related]
29. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy.
Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL
Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876
[TBL] [Abstract][Full Text] [Related]
30. Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma.
Kudoh K; Kikuchi Y; Kita T; Tode T; Takano M; Hirata J; Mano Y; Yamamoto K; Nagata I
Gynecol Obstet Invest; 1999; 47(1):52-7. PubMed ID: 9852392
[TBL] [Abstract][Full Text] [Related]
31. TAG-72 (CA 72-4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring patients with colorectal cancer.
Guadagni F; Roselli M; Cosimelli M; Mannella E; Tedesco M; Cavaliere F; Grassi A; Abbolito MR; Greiner JW; Schlom J
Cancer; 1993 Oct; 72(7):2098-106. PubMed ID: 8374868
[TBL] [Abstract][Full Text] [Related]
32. Comparison of CA 72-4, CA 19-9 and CEA in the diagnosis and monitoring of gastric cancer.
Safi F; Kuhns V; Beger HG
Int J Biol Markers; 1995; 10(2):100-6. PubMed ID: 7561233
[TBL] [Abstract][Full Text] [Related]
33. Macrocreatine kinase type 2 in the serum of patients with tumors and with nonmalignant colonic diseases.
Rogalsky VY; Koven IH; Miller DR; Pollard A
Cancer Detect Prev; 1985; 8(4):477-83. PubMed ID: 4053110
[TBL] [Abstract][Full Text] [Related]
34. [Usefulness of determining tumor markers CEA, CA125 and CA72-4 in blood serum of patients with ovarian carcinoma].
Kokocińska D; Worwag J; Tomala J; Dzieciuchowicz L; Nowak S; Kuśmierski S
Ginekol Pol; 1994 Sep; 65(9):495-501. PubMed ID: 7721162
[TBL] [Abstract][Full Text] [Related]
35. Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer Outcome.
Konishi T; Shimada Y; Hsu M; Tufts L; Jimenez-Rodriguez R; Cercek A; Yaeger R; Saltz L; Smith JJ; Nash GM; Guillem JG; Paty PB; Garcia-Aguilar J; Gonen M; Weiser MR
JAMA Oncol; 2018 Mar; 4(3):309-315. PubMed ID: 29270608
[TBL] [Abstract][Full Text] [Related]
36. Comparison of CA 15-3 and CEA in diagnosis and monitoring of breast cancer.
Safi F; Kohler I; Röttinger E; Suhr P; Beger HG
Int J Biol Markers; 1989; 4(4):207-14. PubMed ID: 2628501
[TBL] [Abstract][Full Text] [Related]
37. [Clinical characteristics and prognosis of colon cancer patient with extremely elevated carcinoembryonic antigen level].
Chen P; Yao Y; Zhang D; Gu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Oct; 18(10):1026-31. PubMed ID: 26499150
[TBL] [Abstract][Full Text] [Related]
38. Serum microRNA-135a-5p as an auxiliary diagnostic biomarker for colorectal cancer.
Wang Q; Zhang H; Shen X; Ju S
Ann Clin Biochem; 2017 Jan; 54(1):76-85. PubMed ID: 27126269
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic Performance of a Novel Multiplex Immunoassay in Colorectal Cancer.
Dressen K; Hermann N; Manekeller S; Walgenbach-Bruenagel G; Schildberg FA; Hettwer K; Uhlig S; Kalff JC; Hartmann G; Holdenrieder S
Anticancer Res; 2017 May; 37(5):2477-2486. PubMed ID: 28476816
[TBL] [Abstract][Full Text] [Related]
40. CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA.
Haglund C; Lundin J; Kuusela P; Roberts PJ
Br J Cancer; 1994 Sep; 70(3):487-92. PubMed ID: 8080735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]